Alveolar and plasma concentrations of interleukin-8 and vascular endothelial growth factor following oesophagectomy

Anaesthesia

Volumn 59, Issue 9, 2004, Pages 867-871

  Cree, R T J ^a   Warnell, I ^a   Staunton, M ^a   Shaw, I ^a   Bullock, R ^a   Griffin, S M ^a   Baudouin, S V ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Acute respiratory distress syndrome; oesophagectomy; Interleukin 8; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 8; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; ESOPHAGOGASTROSTOMY; ESOPHAGUS RESECTION; HIGH RISK POPULATION; HUMAN; LUNG COLLAPSE; LUNG INJURY; LUNG LAVAGE; LUNG VENTILATION; LYMPH NODE DISSECTION; PROTEIN BLOOD LEVEL; RESPIRATORY DISTRESS SYNDROME; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THORACOTOMY; ARTIFICIAL VENTILATION; BLOOD; CHEMISTRY; LUNG ALVEOLUS; METABOLISM; MIDDLE AGED; POSTOPERATIVE PERIOD;

AGED; BRONCHOALVEOLAR LAVAGE FLUID; ESOPHAGECTOMY; HUMANS; INTERLEUKIN-8; MIDDLE AGED; POSTOPERATIVE PERIOD; PULMONARY ALVEOLI; RESPIRATION, ARTIFICIAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4444247237     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2004.03672.x     Document Type: Article

References (23)

1. Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. Cancer of the esophagus and gastroesophageal junction: potentially curative therapies. Surgical Oncology 2001; 10: 113-22.
2. Sherry K. Management of patients undergoing oesophagectomy. In: Gray AJG, Hoile RW, Ingram GS, Sherry K, eds. The Report of the National Confidential Enquiry into Perioperative Deaths 1996/1997. London: The National Confidential Enquiry into Peri-operative Deaths, 1998: 57-61.
3. Tandon S, Batchelor A, Bullock R, et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. British Journal of Anaesthesia 2001; 86: 633-8.
4. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. American Journal of Respiratory and Critical Care Medicine 1997; 155: 1187-205.
5. Donnelly SC, Strieter RM, Kunkel SL, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993; 341: 643-7.
6. Thickett DR, Armstrong L, Christie SJ, Millar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2001; 164: 1601-5.
7. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine 1994; 149: 818-24.
8. Reid PT, Donnelly SC, Haslett C. Inflammatory predictors for the development of the adult respiratory distress syndrome. Thorax 1995; 50: 1023-6.
9. Ekberg-Jansson A, Andersson B, Bake B, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL (CO) and to emphysematous changes on high resolution CT. Respiratory Medicine 2001; 95: 363-73.
10. Meyer KC, Cardoni AL, Xiang Z, Cornwell RD, Love RB. Vascular endothelial growth factor in human lung transplantation. Chest 2001; 119: 137-43.
11. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995; 108: 1303-14.
12. Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. American Journal of Respiratory and Critical Care Medicine 2002; 166: 1332-7.
13. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. European Respiratory Journal 1999; 14: 245-8.
14. Baudouin SV. Lung injury after thoracotomy. British Journal of Anaesthesia 2003; 91: 132-42.
15. Jordan MC, Mitchell JA, Quinlin GJ, Goldstraw P, Evans TW. The pathogenesis of lung injury following pulmonary resection. European Respiratory Journal 2000; 15: 790-9.
16. Nakamura M, Fujishima S, Sawafuji M, et al. Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. American Journal of Respiratory and Critical Care Medicine 2000; 161: 1030-6.
17. Kooguchi K, Kobayashi A, Kitamura Y, et al. Elevated expression of inducible nitric oxide synthase and inflammatory cytokines in the alveolar macrophages after esophagectomy. Critical Care Medicine 2002; 30: 71-6.
18. Sato N, Koeda K, Kimura Y, et al. Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery. European Surgical Research 2001; 33: 279-84.
19. Dos Santos CC, Slutsky AS. Invited review: mechanisms of ventilator-induced lung injury: a perspective. Journal of Applied Physiology 2000; 89: 1645-55.
20. Karmpaliotis D, Kosmidou I, Ingenito EP, et al. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. American Journal of Physiology Lung Cell Molecular Physiology 2002; 283: L585-95.
21. Ware LB, Matthay MA. The acute respiratory distress syndrome. New England Journal of Medicine 2000; 342: 1334-49.
22. Rocker GM, Wiseman MS, Pearson D, Shale DJ. Neutrophil degranulation and increased pulmonary capillary permeability following oesophagectomy: a model of early lung injury in man. British Journal of Surgery 1988; 75: 883-6.
23. Wrigge H, Zinserling J, Stuber F, et al. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function. Anesthesiology 2000; 93: 1413-7.